Treatment of Chronic Myelomonocytic Leukemia with 5-Azacytidine: Case Reports

Figure 1

Bone marrow aspirate (×1000, panoptical staining) from the time of diagnosis; monocyte population (atypical monocytes, promonocytes). The finding was classified as CMML-2 (16% of myeloblasts).